MET and lung adenocarcinoma: Zhang et al. [55] showed that inhibition of DKK1 by miR203 treated with BPI-9016 M, a novel small-molecule c-MET inhibitor, decreased the migration and invasion abilities of lung adenocarcinoma cells, significantly more than c-MET inhibitor alone.